HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)
Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety and the best effective dose of
HuHuangLianzonggan capsule in subjects with nonalcoholic steatohepatitis.